Actively Recruiting
SAFE-ME Predicting Atrial Fibrillation Using Data from Pacemaker and ICD Patients
Led by Medical University of Graz · Updated on 2026-10-16
250
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to better predict atrial fibrillation AF, a condition linked to a greatly increased risk of stroke, in patients who have implanted dual-chamber pacemakers or implantable cardioverter defibrillators ICDs with atrial leads. While current methods can estimate stroke risk in known AF patients, predicting who will develop AF remains challenging. The study seeks to develop accurate algorithms and risk scores by combining clinical data, device information, and electrocardiogram ECG data to improve AF prediction. Participants with implanted pacemakers or ICDs will undergo continuous rhythm monitoring. At the start, clinical and device data will be collected, and participants will have a 24-hour Holter ECG monitoring to gather surface ECG data. After six months, device interrogations will assess the occurrence of AF episodes. The collected data will help create algorithms integrating demographic, clinical, and device parameters to predict AF development more precisely. During the study, participants will be monitored through their implanted devices and the 24-hour Holter ECG at baseline. Researchers will analyze the frequency of atrial high rate episodes over six months. This observational study involves no active treatment but focuses on data collection and rhythm assessment. The total participation lasts at least six months, with regular device checks to evaluate heart rhythm and AF occurrence.
CONDITIONS
Brief Title
Prospective Database for Prediction of Atrial Fibrillation in Pacemaker and ICD Patients
Research Team
D
Daniel Scherr, Assoc.Prof. PD Dr.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here